Fibroblast growth factor 9 (FGF9) inhibits myogenic differentiation of C2C12 and human muscle cells

References

• Burge R, Dawson-Hughes B, Solomon DH, et al. Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025. J Bone Miner Res. 2007;22(3):465–475.
   PubMed Web of Science ®Google Scholar
• Kaji H. Linkage between muscle and bone: common catabolic signals resulting in osteoporosis and sarcopenia. Curr Opin Clin Nutr Metab Care. 2013;16(3):272–277.
   PubMed Web of Science ®Google Scholar
• Mo C, Romero-Suarez S, Bonewald L, et al. Prostaglandin E2: from clinical applications to its potential role in bone- muscle crosstalk and myogenic differentiation. Recent Pat Biotechnol. 2012;6(3):223–229.
   PubMedGoogle Scholar
• Hamrick MW. A role for myokines in muscle-bone interactions. Exerc Sport Sci Rev. 2011;39(1):43–47.
   PubMed Web of Science ®Google Scholar
• Pedersen BK. Muscles and their myokines. J Exp Biol. 2011;214(2):337–346.
   PubMed Web of Science ®Google Scholar
• Norheim F, Raastad T, Thiede B, et al. Proteomic identification of secreted proteins from human skeletal muscle cells and expression in response to strength training. Am J Physiol Endocrinol Metab. 2011;301(5):E1013–21.
   PubMed Web of Science ®Google Scholar
• Elkasrawy MN, Hamrick MW. Myostatin (GDF-8) as a key factor linking muscle mass and bone structure. J Musculoskelet Neuronal Interact. 2010;10(1):56–63.
   PubMed Web of Science ®Google Scholar
• Brekken RA, Sage EH. SPARC, a matricellular protein: at the crossroads of cell-matrix communication. Matrix Biol. 2001;19(8):815–827.
   PubMedGoogle Scholar
• Colaianni G, Cuscito C, Mongelli T, et al. The myokine irisin increases cortical bone mass. Proc Natl Acad Sci U S A. 2015;112(39):12157–12162.
   PubMed Web of Science ®Google Scholar
• Hamrick MW, McNeil PL, Patterson SL. Role of muscle-derived growth factors in bone formation. J Musculoskelet Neuronal Interact. 2010;10(1):64–70.
   PubMed Web of Science ®Google Scholar
• Kitase Y, Vallejo JA, Gutheil W, et al. beta-aminoisobutyric acid, l-BAIBA, is a muscle-derived osteocyte survival factor. Cell Rep. 2018;22(6):1531–1544.
   PubMed Web of Science ®Google Scholar
• Karsenty G, Oury F. Biology without walls: the novel endocrinology of bone. Annu Rev Physiol. 2012;74:87–105.
   PubMed Web of Science ®Google Scholar
• Dallas SL, Prideaux M, Bonewald LF. The osteocyte: an endocrine cell … and more. Endocr Rev. 2013;34(5):658–690.
   PubMed Web of Science ®Google Scholar
• Wagner KR, Fleckenstein JL, Amato AA, et al. A phase I/II trial of MYO-029 in adult subjects with muscular dystrophy. Ann Neurol. 2008;63(5):561–571.
   PubMed Web of Science ®Google Scholar
• Huang J, Romero-Suarez S, Lara N, et al. Crosstalk between MLO-Y4 osteocytes and C2C12 muscle cells is mediated by the Wnt/β-Catenin pathway. JBMR Plus. 2017;1(2):86–100.
   PubMedGoogle Scholar
• Mo C, Zhao R, Vallejo J, et al. Prostaglandin E2 promotes proliferation of skeletal muscle myoblasts via EP4 receptor activation. Cell Cycle (Georgetown, tex). 2015;14(10):1507–1516.
   PubMed Web of Science ®Google Scholar
• Itoh N, Ornitz DM. Functional evolutionary history of the mouse Fgf gene family. Dev Dyn. 2008;237(1):18–27.
   PubMed Web of Science ®Google Scholar
• Yamanaka Y, Lanner F, Rossant J. FGF signal-dependent segregation of primitive endoderm and epiblast in the mouse blastocyst. Development. 2010;137(5):715–724.
   PubMed Web of Science ®Google Scholar
• Jung J, Zheng M, Goldfarb M, et al. Initiation of mammalian liver development from endoderm by fibroblast growth factors. Science (New York, NY). 1999;284(5422):1998–2003.
   Google Scholar
• Presta M, Dell’Era P, Mitola S, et al. Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. Cytokine Growth Factor Rev. 2005;16(2):159–178.
   PubMed Web of Science ®Google Scholar
• Barrientos S, Stojadinovic O, Golinko MS, et al. Growth factors and cytokines in wound healing. Wound Repair Regen. 2008;16(5):585–601.
   PubMed Web of Science ®Google Scholar
• Kharitonenkov A, Shiyanova TL, Koester A, et al. FGF-21 as a novel metabolic regulator. J Clin Invest. 2005;115(6):1627–1635.
   PubMed Web of Science ®Google Scholar
• Turner N, Grose R. Fibroblast growth factor signalling: from development to cancer. Nat Rev Cancer. 2010;10(2):116–129.
   PubMed Web of Science ®Google Scholar
• Ornitz DM, Itoh N. The fibroblast growth factor signaling pathway. WIRES Dev Biol. 2015;4(3):215–266.
   Web of Science ®Google Scholar
• Brewer JR, Mazot P, Soriano P. Genetic insights into the mechanisms of FGF signaling. Genes Dev. 2016;30(7):751–771.
   PubMed Web of Science ®Google Scholar
• Krejci P, Prochazkova J, Bryja V, et al. Molecular pathology of the fibroblast growth factor family. Hum Mutat. 2009;30(9):1245–1255.
   PubMed Web of Science ®Google Scholar
• Itoh N, Nakayama Y, Konishi M. Roles of FGFs as paracrine or endocrine signals in liver development, health, and disease. Front Cell Dev Biol. 2016;4:30.
   PubMed Web of Science ®Google Scholar
• Javed A, Chen H, Ghori FY. Genetic and transcriptional control of bone formation. Oral Maxillofac Surg Clin North Am. 2010;22(3):283–293.
   PubMed Web of Science ®Google Scholar
• Pawlikowski B, Vogler TO, Gadek K, et al. Regulation of skeletal muscle stem cells by fibroblast growth factors. Dev Dyn. 2017;246(5):359–367.
   PubMed Web of Science ®Google Scholar
• Lu H, Shi X, Wu G, et al. FGF13 regulates proliferation and differentiation of skeletal muscle by down-regulating spry1. Cell Prolif. 2015;48(5):550–560.
   PubMed Web of Science ®Google Scholar
• Benoit B, Meugnier E, Castelli M, et al. Fibroblast growth factor 19 regulates skeletal muscle mass and ameliorates muscle wasting in mice. Nat Med. 2017;23(8):990–996.
   PubMed Web of Science ®Google Scholar
• Miyake A, Konishi M, Martin FH, et al. Structure and expression of a novel member, FGF-16, on the fibroblast growth factor family. Biochem Biophys Res Commun. 1998;243(1):148–152.
   PubMed Web of Science ®Google Scholar
• Ohmachi S, Watanabe Y, Mikami T, et al. FGF-20, a novel neurotrophic factor, preferentially expressed in the substantia nigra pars compacta of rat brain. Biochem Biophys Res Commun. 2000;277(2):355–360.
   PubMed Web of Science ®Google Scholar
• Wang S, Li Y, Jiang C, et al. Fibroblast growth factor 9 subfamily and the heart. Appl Microbiol Biotechnol. 2018;102(2):605–613.
   PubMed Web of Science ®Google Scholar
• Schmid GJ, Kobayashi C, Sandell LJ, et al. Fibroblast growth factor expression during skeletal fracture healing in mice. Dev Dyn. 2009;238(3):766–774.
   PubMed Web of Science ®Google Scholar
• Charoenlarp P, Rajendran AK, Iseki S. Role of fibroblast growth factors in bone regeneration. Inflamm Regen. 2017;37:10.
   PubMed Web of Science ®Google Scholar
• Hajihosseini MK, Heath JK. Expression patterns of fibroblast growth factors-18 and −20 in mouse embryos is suggestive of novel roles in calvarial and limb development. Mech Dev. 2002;113(1):79–83.
   PubMed Web of Science ®Google Scholar
• Kim GJ, Kumano G, Nishida H. Cell fate polarization in ascidian mesenchyme/muscle precursors by directed FGF signaling and role for an additional ectodermal FGF antagonizing signal in notochord/nerve cord precursors. Development. 2007;134(8):1509–1518.
   PubMed Web of Science ®Google Scholar
• Yi L, Domyan ET, Lewandoski M, et al. Fibroblast growth factor 9 signaling inhibits airway smooth muscle differentiation in mouse lung. Dev Dyn. 2009;238(1):123–137.
   PubMed Web of Science ®Google Scholar
• McCormick LA, Wang K, Tiede-Lewis LM, et al. Role of FGF9 in promotion of early osteocyte differentiation and as a potent inducer of fgf23 expression in osteocytes. J Bone Miner Res. 2016;31(Suppl 1):S39.
   Google Scholar
• Wang K, Le L, Chun BM, et al. A novel osteogenic cell line that differentiates into GFP-tagged osteocytes and forms mineral with a bone-like lacunocanalicular structure. J Bone Miner Res. 2019;34(6):979–995.
   Web of Science ®Google Scholar
• Huang J, Hsu YH, Mo C, et al. METTL21C is a potential pleiotropic gene for osteoporosis and sarcopenia acting through the modulation of the nf-kappa B signaling pathway. J Bone Miner Res. 2014;29(7):1531–1540.
   PubMed Web of Science ®Google Scholar
• Ono Y, Sakamoto K. Lipopolysaccharide inhibits myogenic differentiation of C2C12 myoblasts through the Toll-like receptor 4-nuclear factor-kappaB signaling pathway and myoblast-derived tumor necrosis factor-alpha. PloS One. 2017;12(7):e0182040.
   PubMed Web of Science ®Google Scholar
• Jahn K, Lara-Castillo N, Brotto L, et al. Skeletal muscle secreted factors prevent glucocorticoid-induced osteocyte apoptosis through activation of beta-catenin. Eur Cell Mater. 2012;24:197–209, discussion −10
   PubMed Web of Science ®Google Scholar
• Shen J, Yu WM, Brotto M, et al. Deficiency of MIP/MTMR14 phosphatase induces a muscle disorder by disrupting Ca(2+) homeostasis. Nat Cell Biol. 2009;11(6):769–776.
   PubMed Web of Science ®Google Scholar
• Filigheddu N, Gnocchi VF, Coscia M, et al. Ghrelin and des-acyl ghrelin promote differentiation and fusion of C2C12 skeletal muscle cells. Mol Biol Cell. 2007;18(3):986–994.
   PubMed Web of Science ®Google Scholar
• Zhao X, Weisleder N, Thornton A, et al. Compromised store-operated Ca2+ entry in aged skeletal muscle. Aging Cell. 2008;7(4):561–568.
   PubMed Web of Science ®Google Scholar
• Avin KG, Vallejo JA, Chen NX, et al. Fibroblast growth factor 23 does not directly influence skeletal muscle cell proliferation and differentiation or ex vivo muscle contractility. Am J Physiol Endocrinol Metab. 2018;315:E594-E604.
   PubMed Web of Science ®Google Scholar
• Porter GA Jr., Makuck RF, Rivkees SA. Reduction in intracellular calcium levels inhibits myoblast differentiation. J Biol Chem. 2002;277(32):28942–28947.
   PubMed Web of Science ®Google Scholar
• Clegg CH, Linkhart TA, Olwin BB, et al. Growth factor control of skeletal muscle differentiation: commitment to terminal differentiation occurs in G1 phase and is repressed by fibroblast growth factor. J Cell Biol. 1987;105(2):949–956.
   PubMed Web of Science ®Google Scholar
• Spizz G, Roman D, Strauss A, et al. Serum and fibroblast growth factor inhibit myogenic differentiation through a mechanism dependent on protein synthesis and independent of cell proliferation. J Biol Chem. 1986;261(20):9483–9488.
   PubMed Web of Science ®Google Scholar
• Justet A, Joannes A, Besnard V, et al. FGF9 prevents pleural fibrosis induced by intrapleural adenovirus injection in mice. Am J Physiol Lung Cell Mol Physiol. 2017;313(5):L781–l95.
   PubMed Web of Science ®Google Scholar
• El Agha E, Kheirollahi V, Moiseenko A, et al. Ex vivo analysis of the contribution of FGF10(+) cells to airway smooth muscle cell formation during early lung development. Dev Dyn. 2017;246(7):531–538.
   PubMed Web of Science ®Google Scholar
• Ridgeway AG, Petropoulos H, Wilton S, et al. Wnt signaling regulates the function of MYoD and myogenin. J Biol Chem. 2000;275(42):32398–32405.
   PubMed Web of Science ®Google Scholar
• McPherron AC, Lawler AM, Lee SJ. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature. 1997;387(6628):83–90.
   PubMed Web of Science ®Google Scholar
• Langley B, Thomas M, Bishop A, et al. Myostatin inhibits myoblast differentiation by down-regulating MyoD expression. J Biol Chem. 2002;277(51):49831–49840.
   PubMed Web of Science ®Google Scholar
• Rios R, Carneiro I, Arce VM, et al. Myostatin is an inhibitor of myogenic differentiation. Am J Physiol Cell Physiol. 2002;282(5):C993–9.
   PubMed Web of Science ®Google Scholar
• Brunetti A, Goldfine ID. Role of myogenin in myoblast differentiation and its regulation by fibroblast growth factor. J Biol Chem. 1990;265(11):5960–5963.
   PubMed Web of Science ®Google Scholar
• Thornton AM, Zhao X, Weisleder N, et al. Store-operated Ca(2+) entry (SOCE) contributes to normal skeletal muscle contractility in young but not in aged skeletal muscle. Aging (Albany NY). 2011;3(6):621–634.
   PubMedGoogle Scholar
• Park KH, Brotto L, Lehoang O, et al. Ex vivo assessment of contractility, fatigability and alternans in isolated skeletal muscles. J Vis Exp. 2012;(69):e4198.
   Google Scholar
• Stern HM, Brown AM, Hauschka SD. Myogenesis in paraxial mesoderm: preferential induction by dorsal neural tube and by cells expressing Wnt-1. Development. 1995;121(11):3675–3686.
   PubMed Web of Science ®Google Scholar
• Porter JD, Baker RS. Absence of oculomotor and trochlear motoneurons leads to altered extraocular muscle development in the Wnt-1 null mutant mouse. Brain Res Dev Brain Res. 1997;100(1):121–126.
   PubMedGoogle Scholar
• Hitchins L, Fletcher F, Allen S, et al. Role of Sulf1A in Wnt1- and Wnt6-induced growth regulation and myoblast hyper-elongation. FEBS Open Bio. 2013;3:30–34.
   PubMed Web of Science ®Google Scholar
• Dearth CL, Goh Q, Marino JS, et al. Skeletal muscle cells express ICAM-1 after muscle overload and ICAM-1 contributes to the ensuing hypertrophic response. PloS One. 2013;8(3):e58486.
   PubMed Web of Science ®Google Scholar
• Goh Q, Dearth CL, Corbett JT, et al. Intercellular adhesion molecule-1 expression by skeletal muscle cells augments myogenesis. Exp Cell Res. 2015;331(2):292–308.
   PubMed Web of Science ®Google Scholar
• Schartner V, Romero NB, Donkervoort S, et al. Dihydropyridine receptor (DHPR, CACNA1S) congenital myopathy. Acta Neuropathol. 2017;133(4):517–533.
   PubMed Web of Science ®Google Scholar
• Waddell HMM, Zhang JZ, Hoeksema KJ, et al. Oxidation of ryr2 has a biphasic effect on the threshold for store overload-induced calcium release. Biophys J. 2016;110(11):2386–2396.
   PubMed Web of Science ®Google Scholar
• Jiang D, Xiao B, Yang D, et al. RyR2 mutations linked to ventricular tachycardia and sudden death reduce the threshold for store-overload-induced Ca2+ release (SOICR). Proc Natl Acad Sci U S A. 2004;101(35):13062–13067.
   PubMed Web of Science ®Google Scholar
• Phuong TT, Yun YH, Kim SJ, et al. Positive feedback control between STIM1 and NFATc3 is required for C2C12 myoblast differentiation. Biochem Biophys Res Commun. 2013;430(2):722–728.
   PubMed Web of Science ®Google Scholar
• Scharenberg AM, Kinet JP. PtdIns-3,4,5-P3: a regulatory nexus between tyrosine kinases and sustained calcium signals. Cell. 1998;94(1):5–8.
   PubMed Web of Science ®Google Scholar
• Yi JS, Park JS, Ham YM, et al. MG53-induced IRS-1 ubiquitination negatively regulates skeletal myogenesis and insulin signalling. Nat Commun. 2013;4:2354.
   PubMed Web of Science ®Google Scholar
• Weisleder N, Takizawa N, Lin P, et al. Recombinant MG53 protein modulates therapeutic cell membrane repair in treatment of muscular dystrophy. Sci Transl Med. 2012;4(139):139ra85.
   PubMed Web of Science ®Google Scholar
• Weisleder N, Takeshima H, Ma J. Immuno-proteomic approach to excitation–contraction coupling in skeletal and cardiac muscle: molecular insights revealed by the mitsugumins. Cell Calcium. 2008;43(1):1–8.
   PubMed Web of Science ®Google Scholar
• Brzeszczynska J, Meyer A, McGregor R, et al. Alterations in the in vitro and in vivo regulation of muscle regeneration in healthy ageing and the influence of sarcopenia. J Cachexia Sarcopenia Muscle. 2018;9(1):93–105.
   PubMed Web of Science ®Google Scholar
• Vina J, Gomez-Cabrera MC, Borras C, et al. Mitochondrial biogenesis in exercise and in ageing. Adv Drug Deliv Rev. 2009;61(14):1369–1374.
   PubMed Web of Science ®Google Scholar
• Powell JA, Carrasco MA, Adams DS, et al. IP(3) receptor function and localization in myotubes: an unexplored Ca(2+) signaling pathway in skeletal muscle. J Cell Sci. 2001;114(Pt 20):3673–3683.
   PubMed Web of Science ®Google Scholar
• Rizzuto R, Duchen MR, Pozzan T. Flirting in little space: the ER/mitochondria Ca2+ liaison. Sci STKE. 2004;2004(215):re1.
   PubMedGoogle Scholar
• Berchtold MW, Brinkmeier H, Muntener M. Calcium ion in skeletal muscle: its crucial role for muscle function, plasticity, and disease. Physiol Rev. 2000;80(3):1215–1265.
   PubMed Web of Science ®Google Scholar
• Periasamy M, Kalyanasundaram A. SERCA pump isoforms: their role in calcium transport and disease. Muscle Nerve. 2007;35(4):430–442.
   PubMed Web of Science ®Google Scholar
• Kizhner T, Ben-David D, Rom E, et al. Effects of FGF2 and FGF9 on osteogenic differentiation of bone marrow-derived progenitors. In Vitro Cell Dev Biol Anim. 2011;47(4):294–301.
   PubMed Web of Science ®Google Scholar
• Sontag DP, Cattini PA. Cloning and bacterial expression of postnatal mouse heart FGF-16. Mol Cell Biochem. 2003;242(1–2):65–70.
   PubMed Web of Science ®Google Scholar
• Zhang X, Ibrahimi OA, Olsen SK, et al. Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family. J Biol Chem. 2006;281(23):15694–15700.
   PubMed Web of Science ®Google Scholar
• Colvin JS, White AC, Pratt SJ, et al. Lung hypoplasia and neonatal death in Fgf9-null mice identify this gene as an essential regulator of lung mesenchyme. Development. 2001;128(11):2095–2106.
   PubMed Web of Science ®Google Scholar
• Wang L, Roth T, Abbott M, et al. Osteoblast-derived FGF9 regulates skeletal homeostasis. Bone. 2017;98:18–25.
   PubMed Web of Science ®Google Scholar
• Behr B, Leucht P, Longaker MT, et al. Fgf-9 is required for angiogenesis and osteogenesis in long bone repair. Proc Natl Acad Sci U S A. 2010;107(26):11853–11858.
   PubMed Web of Science ®Google Scholar
• Davidson B, Shi W, Beh J, et al. FGF signaling delineates the cardiac progenitor field in the simple chordate, Ciona intestinalis. Genes Dev. 2006;20(19):2728–2738.
   PubMed Web of Science ®Google Scholar
• Wang S, Lin H, Zhao T, et al. Expression and purification of an FGF9 fusion protein in E. coli, and the effects of the FGF9 subfamily on human hepatocellular carcinoma cell proliferation and migration. Appl Microbiol Biotechnol. 2017;101(21):7823–7835.
   PubMed Web of Science ®Google Scholar
• White AC, Xu J, Yin Y, et al. FGF9 and SHH signaling coordinate lung growth and development through regulation of distinct mesenchymal domains. Development. 2006;133(8):1507–1517.
   PubMed Web of Science ®Google Scholar
• Chang MM, Lai MS, Hong SY, et al. FGF9/FGFR2 increase cell proliferation by activating ERK1/2, Rb/E2F1 and cell cycle pathways in mouse Leydig tumor cells. Cancer science. 2018;109(11):3503–3518.
   Web of Science ®Google Scholar
• Agrotis A, Kanellakis P, Kostolias G, et al. Proliferation of neointimal smooth muscle cells after arterial injury. J Biol Chem. 2004;279(40):42221–42229.
   PubMed Web of Science ®Google Scholar
• Lavine KJ, Yu K, White AC, et al. Endocardial and epicardial derived FGF signals regulate myocardial proliferation and differentiation in vivo. Dev Cell. 2005;8(1):85–95.
   PubMed Web of Science ®Google Scholar
• Hotta Y, Sasaki S, Konishi M, et al. Fgf16 is required for cardiomyocyte proliferation in the mouse embryonic heart. Dev Dyn. 2008;237(10):2947–2954.
   PubMed Web of Science ®Google Scholar
• Lefaucheur JP, Sebille A. Basic fibroblast growth factor promotes in vivo muscle regeneration in murine muscular dystrophy. Neurosci Lett. 1995;202(1–2):121–124.
   PubMed Web of Science ®Google Scholar
• Thomas CN, Berry M, Logan A, et al. Caspases in retinal ganglion cell death and axon regeneration. Cell Death Discov. 2017;3:17032.
   PubMed Web of Science ®Google Scholar
• Gomez-Sanchez R, Yakhine-Diop SM, Rodriguez-Arribas M, et al. mRNA and protein dataset of autophagy markers (LC3 and p62) in several cell lines. Data Brief. 2016;7:641–647.
   PubMed Web of Science ®Google Scholar